EMPLOYMENT AGREEMENTEmployment Agreement • July 9th, 2014 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances • New York
EMPLOYMENT AGREEMENT (the “Agreement”) dated as of June 4, 2014 by and between Lantheus Medical Imaging, Inc., a Delaware corporation (the “Company”) and John Bakewell (“Executive”).
LANTHEUS HOLDINGS, INC. Restricted Stock AgreementRestricted Stock Agreement • July 9th, 2014 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS AGREEMENT (the “Agreement”) is made between Lantheus Holdings, Inc., a Delaware corporation (the “Company”), and _________ (the “Participant”), effective _________ (the “Effective Date”).
AMENDMENT NUMBER ONE TO AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • July 9th, 2014 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances
THIS AMENDMENT NUMBER ONE TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”), dated as of June 24, 2014, is entered into by and among LANTHEUS MI INTERMEDIATE, INC., a Delaware corporation (the “Parent”), LANTHEUS MEDICAL IMAGING, INC., a Delaware corporation (the “Borrower”), the lenders identified on the signature pages hereof (such lenders, and the other lenders party to the below-defined Credit Agreement, together with their respective successors and permitted assigns, each individually, a “Lender”, and collectively, the “Lenders”), each subsidiary of the Parent listed as a “Guarantor” on the signature pages hereto (together with the Parent, each a “Guarantor” and individually and collectively, jointly and severally, the “Guarantors”; Borrower and Guarantors, each a “Loan Party” and individually and collectively, jointly and severally, the “Loan Parties”), and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, in its capacity as collateral agent for th
LANTHEUS HOLDINGS, INC. Stock Option Agreement – Time VestingStock Option Agreement • July 9th, 2014 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS AGREEMENT (the “Agreement”) is made effective as of _________ (the “Date of Grant”) by and between Lantheus Holdings, Inc., a Delaware corporation (the “Company”), and _________ (the “Participant”).
FORM OF AMENDMENT TO THE AMENDED AND RESTATED SHAREHOLDERS AGREEMENTShareholder Agreements • July 9th, 2014 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances • New York
FORM OF AMENDMENT TO THE EMPLOYEE SHAREHOLDERS AGREEMENTEmployee Shareholders Agreement • July 9th, 2014 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances • New York
WHEREAS, the undersigned parties to this amendment (this “Amendment”) are parties to that certain Employee Shareholders Agreement, dated as of May 8, 2008 (as may be amended from time to time, the “Agreement”), among (i) Lantheus MI Holdings, Inc., a Delaware corporation (the “Company”), (ii) Avista Capital Partners, L.P., a Delaware limited partnership, Avista Capital Partners (Offshore), L.P., a Delaware limited partnership, and ACP Lantern Co-Invest, LLC, a Delaware limited liability company (each of the foregoing in this clause (ii), an “Avista Entity” and, collectively, the “Avista Entities”), and (iii) each person listed as an “Employee Shareholder” on the signature pages thereto or that has subsequently become a party to the Agreement as an “Employee Shareholder” (each an “Employee Shareholder” and, collectively, the “Employee Shareholders”);
